Description
Exenatide, marketed under the brand name BYETTA, It is an prescription medication that has been approved exenatide on April 28, 2005. Exenatide is a glucagon-like peptide-1 (GLP-1) analog used to treat type 2 diabetes.
What is BYETTA (Exenatide) ?
BYETTA is an injectable prescription medicine that may improve blood sugar (glucose) control in adults with type 2 diabetes mellitus, when used with a diet and exercise program.
BYETTA is not insulin.
You should not take BYETTA instead of insulin.
The use of BYETTA with short acting insulin is not recommended.
The use of BYETTA with rapid acting insulin is not recommended.
BYETTA is not for people with type 1 diabetes or people with diabetic ketoacidosis.
It is not known if BYETTA is safe and effective in children.
BYETTA has not been studied in people who have pancreatitis.
BYETTA should not be used in people who have severe kidney problems.
Exenatide is a glucagon-like peptide-1 receptor agonist medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2.
How to order approved “BYETTA (Exenatide) for Injection” Medicine?
BYETTA (Exenatide) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing BYETTA and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
